PRIMECAP MANAGEMENT CO/CA/ - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRIMECAP MANAGEMENT CO/CA/ ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$796,736
-18.8%
146,1900.0%0.00%0.0%
Q2 2023$980,935
-24.0%
146,1900.0%0.00%0.0%
Q1 2023$1,290,858
+15.6%
146,1900.0%0.00%0.0%
Q4 2022$1,116,892
+4.2%
146,190
-2.9%
0.00%0.0%
Q3 2022$1,072,000
-12.0%
150,5000.0%0.00%0.0%
Q2 2022$1,218,000
-55.1%
150,500
-23.0%
0.00%
-50.0%
Q1 2022$2,714,000
-51.8%
195,500
-2.5%
0.00%
-50.0%
Q4 2021$5,626,000
-19.5%
200,500
-2.4%
0.00%
-20.0%
Q3 2021$6,985,000
-22.1%
205,500
-6.4%
0.01%
-16.7%
Q2 2021$8,969,000
+5.8%
219,500
+4.3%
0.01%0.0%
Q1 2021$8,475,000
+11.5%
210,500
+63.8%
0.01%0.0%
Q4 2020$7,598,000
-9.4%
128,500
-25.5%
0.01%
-14.3%
Q3 2020$8,389,000
+15.2%
172,500
+14.6%
0.01%
+16.7%
Q2 2020$7,281,000
+74.1%
150,5000.0%0.01%
+50.0%
Q1 2020$4,181,000150,5000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders